Luigi Francesco Iannone

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Kanyin Liane Ong, Damian Santomauro, A Bhoomadevi et al. · The Lancet · 2025 · 413 citations · Full text

Public Health, Health Sciences, Epidemiology +16

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Hmwe Hmwe Kyu, A Bhoomadevi, Mohammad Amin Aalipour et al. · The Lancet · 2025 · 275 citations · Full text

Public Health, Demography, Population Health Sciences +17

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

Peng Zheng, Ryan M Barber, A Bhoomadevi et al. · The Lancet · 2025 · 103 citations · Full text

Public Health, Demography, Population Health Sciences +17

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score

Luigi Francesco Iannone, Davide Fattori, Silvia Benemei et al. · CNS Drugs · 2022 · 88 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat

Rita Citraro, Francesca Lembo, Carmen De et al. · Epilepsia · 2021 · 74 citations

Life Sciences, Neurobiology, Neuroscience +17